FinscoFinsco

Amgen (US.AMGN)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.AMGN · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion67.5%→
ROE19.8%↓
Cash Conversion120.3%↑
D/E Ratio6.24↑
Gross Margin68.2%↑
US.AMGN (Amgen) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion    67.5%    →
ROE               19.8%    ↓
Cash Conversion  120.3%    ↑
D/E Ratio          6.24    ↑
Gross Margin      68.2%    ↑
Key Metrics
US.AMGN (Amgen) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 67.5% →
ROE 19.8% ↓
Cash Conversion 120.3% ↑
D/E Ratio 6.24 ↑
Gross Margin 68.2% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies